Legal Representation
Attorney
CATHERINE C MILLER
USPTO Deadlines
Next Deadline
886 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20220607)
Due Date
June 07, 2028
Grace Period Ends
December 07, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
42 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 10, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Sep 19, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 19, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 7, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 7, 2022 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Jun 7, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jun 7, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 29, 2022 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
| Apr 15, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Apr 4, 2022 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Apr 1, 2022 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Mar 16, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 16, 2022 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Feb 15, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 15, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 14, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jan 26, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jan 26, 2022 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Jan 26, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 13, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 6, 2022 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Jan 6, 2022 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Jan 6, 2022 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Dec 31, 2021 | CHLD | M | CHANGE OF OWNER RECEIVED FROM IB | Loading... |
| Dec 30, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 30, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 30, 2021 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jul 8, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jul 8, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jul 8, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jul 2, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 1, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 1, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 24, 2021 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jan 5, 2021 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jan 4, 2021 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Dec 17, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Dec 16, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 15, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 23, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Oct 19, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 15, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, in particular for the prevention and treatment of cancer, infectious diseases, autoimmune diseases and other immunological diseases, in particular by means of nucleic acids, self-replicating nucleic acids, viruses, virus-like particles, peptides and proteins; nucleic acids coding for receptor proteins for the stimulation and proliferation of cells of the immune system for medical purposes; all the foregoing for human use
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Medical and scientific research, in particular in the field of the prevention and treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; scientific research services relating to pharmaceutical information, the rendering of scientific research advice in the field of the prevention and treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; all the foregoing for human use
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services, in particular providing therapeutic methods and vaccination methods for the treatment and prevention of cancer, infectious diseases and immunological diseases; medical and pharmaceutical advisory services; medical diagnostic testing, monitoring and reporting services; medical services relating to information in the nature of providing medical information, the rendering of medical advice in the field of the prevention and the treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; all the foregoing for human use
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042
044